Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 6,426–6,450 of 7,816 matching trials · page 258 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Individual and Group Intervention Formats With Aggressive Children NCT01710969 Individual intervention; Group Intervention |
NA other |
COMPLETED | 360 | National Institute on Drug Abuse (NIDA) NIH |
2017-01-11 |
|
"Living Together With Dementia"_Creation and Validation of a Training Program for Family Caregivers of People With Dementia to Live at Home NCT03015428 psychoeducation Runs in: Portugal · 1 site |
NA other |
COMPLETED | 25 | Centro Hospitalar De São João, E.P.E. OTHER |
2017-01-10 |
|
Development of NIC5-15 in the Treatment of Alzheimer's Disease NCT00470418 NIC5-15; Placebo Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 15 | VA Office of Research and Development OTHER_GOV |
2017-01-09 |
|
Treatment of Language and Memory in Patients With Alzheimer's Disease NCT00593372 Spaced Retrieval Training Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 11 | University of Arkansas OTHER |
2017-01-09 |
|
A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions NCT00870974 [18F]FPEB Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 48 | Institute for Neurodegenerative Disorders OTHER |
2017-01-06 |
|
Evaluation of [123I]MNI-420 and SPECT as a Marker of the Adenosine A2a Receptor in PD, HD and Healthy Subjects. NCT00970229 [123I]MNI-420 Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 19 | Institute for Neurodegenerative Disorders OTHER |
2017-01-06 |
|
Behavioral and Neuroimaging Changes After Cognitive Rehab in Traumatic Brain Injuries (TBI) and Mild Cognitive Impairment (MCI) NCT00714571 Mnemonic strategy training (MST); Repeated exposure (XP); Subtracti... Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 82 | VA Office of Research and Development OTHER_GOV |
2017-01-04 |
|
Non-pharmacological Care of Alzheimer's Disease: Benefice of Musical Interventions NCT02833870 Musical intervention; Non-musical (cooking) intervention; Control w... Runs in: France · 1 site |
NA other |
COMPLETED | 150 | CHU de Reims OTHER |
2017-01-02 |
|
Evaluation of E2609 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (Study: E2609-A001-101 Amendment 02) NCT01600859 E2609; Placebo for E2609 Runs in: United States · 2 sites |
PHASE1 other |
COMPLETED | 65 | Eisai Inc. INDUSTRY |
2016-12-30 |
|
A Multi-national Study to Identify Treatment Discontinuation Rate in de Novo Alzheimer's Disease Patients Who Have Been Newly Prescribed With Donepezil (Aricept) in Asia (ADOS) NCT02262975 Runs in: China; Philippines; Singapore; South Korea; Taiwan; Thailand · 26 sites |
NA symptomatic-cholinergic |
COMPLETED | 532 | Eisai Korea Inc. INDUSTRY |
2016-12-28 |
|
An Innovative Caregiver Tool to Assess and Manage Behavioral Symptoms of Dementia NCT02420535 Immediately Receive Tool; One Month Delay Runs in: United States · 2 sites |
NA other |
COMPLETED | 114 | University of Michigan OTHER |
2016-12-19 |
|
Efficacy and Safety of MNI-672 SPECT for Detection/Exclusion of Cerebral B-amyloid in AD Subjects Compared to HVs. NCT01859767 [123I]MNI-672 SPECT Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 6 | Molecular NeuroImaging OTHER |
2016-12-16 |
|
Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects NCT02103894 [18F]T807 ([18F]MNI-777) Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 16 | Molecular NeuroImaging OTHER |
2016-12-16 |
|
Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Tauopathies NCT02531360 [18F]MNI-815 (MNI-815) Runs in: United States · 1 site |
EARLY_PHASE1 other |
COMPLETED | 7 | Molecular NeuroImaging OTHER |
2016-12-16 |
|
Study to Determine the Effect of Itraconazole on the Pharmacokinetics of Rilapladib (SB659032) in Healthy Volunteers NCT02130661 Rilapladib 25 mg; Rilapladib 250 mg; Itraconazole |
PHASE1 other |
WITHDRAWN | 0 | GlaxoSmithKline INDUSTRY |
2016-12-13 |
|
Neurofeedback as a Novel Treatment for Mild Cognitive Impairment & Early Alzheimer's Disease NCT02987842 TruScan Neurofeedback Runs in: Israel · 1 site |
NA other |
UNKNOWN | 30 | Beersheva Mental Health Center OTHER_GOV |
2016-12-13 |
|
Tai Chi 6-Form Sports Apparatus With Alzheimer's Disease NCT02978768 Exercise; Computer-based cognitive training; Physico-Mental rehabil... Runs in: Taiwan · 1 site |
NA other |
COMPLETED | 67 | Chang Gung Memorial Hospital OTHER |
2016-12-12 |
|
Brief Behavioural Treatment for Insomnia in Dementia Carers NCT02983032 BBTI Runs in: United Kingdom · 1 site |
NA other |
UNKNOWN | 15 | NHS Greater Glasgow and Clyde OTHER |
2016-12-12 |
|
A Single Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease. NCT02377713 KHK6640; Placebo Runs in: Japan · 1 site |
PHASE1 other |
COMPLETED | 20 | Kyowa Kirin Co., Ltd. INDUSTRY |
2016-12-07 |
|
Research on Pathophysiology and Treatment in Depression Using Brain Derived Neurotrophic Factor and Amyloid Neuroimaging NCT02983838 Runs in: South Korea · 1 site |
NA other |
UNKNOWN | 60 | Samsung Medical Center OTHER |
2016-12-06 |
|
Study of Motor Slowing in Parkinson's Disease by a Computerized Mental Chronometry Paradigm NCT02814201 SRT Runs in: France · 1 site |
NA other |
COMPLETED | 55 | Centre Hospitalier Universitaire, Amiens OTHER |
2016-12-05 |
|
German Adaptation of REACH II NCT01690117 GE-REACH-program Runs in: Germany · 1 site |
NA other |
COMPLETED | 92 | University of Leipzig OTHER |
2016-11-29 |
|
Meditation to Reduce Caregiver Stress NCT01537679 Kirtan Kriya meditation; Relaxation Runs in: United States · 1 site |
NA other |
COMPLETED | 40 | University of California, Los Angeles OTHER |
2016-11-28 |
|
Effects of Vitamin D3 Supplementation on Cognitive Function in Community Dwelling Older Adults NCT02804841 Cholecalciferol -Vitamin D3; Placebo -gel capsule containing no vitamin D. Runs in: Ireland · 1 site |
NA other |
COMPLETED | 60 | University of Dublin, Trinity College OTHER |
2016-11-22 |
|
Mass Practice of Activities of Daily Living in Dementia (STOMP) NCT02356055 STOMP (Skill-building through Task-Oriented Motor Practice) |
NA other |
COMPLETED | 32 | University of Oklahoma OTHER |
2016-11-21 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial